Champions Oncology (CSBR) Non-Current Assets (2011 - 2026)

Champions Oncology's Non-Current Assets history runs 16 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 24.41% year-over-year to $8.3 million; the TTM figure through Jan 2026 stood at $36.6 million (down 20.99% YoY), while the FY2025 annual figure was $10.0 million, down 20.07% from the prior year.
• Non-Current Assets was $8.3 million for Q1 2026 at Champions Oncology, down from $8.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $16.0 million in Q3 2022 to a low of $8.3 million in Q1 2026.
• Historically, Non-Current Assets has averaged $12.9 million across 5 years, with a median of $13.6 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Non-Current Assets surged 39.57% in 2022, then decreased 24.41% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $15.8 million in 2022, then declined by 9.39% to $14.3 million in 2023, then decreased by 21.86% to $11.2 million in 2024, then retreated by 20.85% to $8.8 million in 2025, then dropped by 6.43% to $8.3 million in 2026.
• The last three Non-Current Assets figures came in at $8.3 million (Q1 2026), $8.8 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.